These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6776756)

  • 21. [Effect of dopaminergic stimulation on growth hormone and prolactin in the treatment of acromegaly].
    Nedvídková J; Felt V
    Vnitr Lek; 1980 Oct; 26(10):988-93. PubMed ID: 7467150
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
    Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bromocriptine in the medical management of acromegaly.
    Besser GM; Wass JA; Thorner MO
    Adv Biochem Psychopharmacol; 1980; 23():191-8. PubMed ID: 6249090
    [No Abstract]   [Full Text] [Related]  

  • 24. Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegaly.
    Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Liuzzi A; Chiodini PG
    J Clin Endocrinol Metab; 1986 Mar; 62(3):601-4. PubMed ID: 3080469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No effect of bromocriptine in acromegaly: a controlled trial.
    Lindholm J; Riishede J; Vestergaard S; Hummer L; Faber O; Hagen C
    N Engl J Med; 1981 Jun; 304(24):1450-4. PubMed ID: 7015129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dynamics of growth hormone and prolactin secretion in acromegalic patients with "mixed" pituitary tumours.
    Lamberts SW; Klijn JG; Kwa GH; Birkenhäger JC
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):198-210. PubMed ID: 105530
    [No Abstract]   [Full Text] [Related]  

  • 27. [TRH-stimulated growth hormone secretion in acromegaly. Therapeutic results with 188 patients].
    Eversmann T; Lüdeke U; Fahlbusch R; von Werder K
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1091-6. PubMed ID: 3089753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.
    Ishibashi M; Yamaji T; Kosaka K
    J Clin Endocrinol Metab; 1977 Aug; 45(2):275-9. PubMed ID: 407240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum growth hormone and ultrastructural studies of adenohypophysial tissue in bromocriptine treated acromegalic patients.
    Fanghanel-S G; Larraza O; Arauco R; Esquivel R; Martinez Campos A; Valverde-R C
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):289-96. PubMed ID: 102468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
    Barrera CM; Ruiz AE; Banks WA
    Horm Res; 1991; 35(3-4):167-9. PubMed ID: 1806471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experiences with bromocriptine treatment in acromegaly--a preliminary report.
    Nilsson A
    Acta Endocrinol Suppl (Copenh); 1978; 216():217-24. PubMed ID: 274038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pirenzepine, bromocriptine and their association on basal and GHRH- and TRH-induced GH secretion in acromegaly.
    Fiszlejder L; Penacini O; Ratz S; Storani M; Oneto A; Guitelman A
    Horm Res; 1991; 36(1-2):47-51. PubMed ID: 1814801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
    Cantalamessa L; Reschini E; Catania A; Giustina G
    Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood acromegaly: successful therapy with conventional radiation and effects of chlorpromazine on growth hormone and prolactin secretion.
    AvRuskin TW; Sau K; Tang S; Juan C
    J Clin Endocrinol Metab; 1973 Sep; 37(3):380-8. PubMed ID: 4206490
    [No Abstract]   [Full Text] [Related]  

  • 35. The interaction of GHRH with TRH in acromegaly: a controlled study.
    Looij BJ; Roelfsema F; Frölich M; Nieuwenhuijzen Kruseman AC
    Acta Endocrinol (Copenh); 1991 Oct; 125(4):337-41. PubMed ID: 1957553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly.
    Merola B; Colao A; Cataldi M; Rossi E; Longobardi S; Caruso E; Lombardi G
    Horm Res; 1992; 37(1-2):7-13. PubMed ID: 1356902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of acromegaly with bromocriptine.
    Steinbeck K; Turtle JR
    Med J Aust; 1978 Nov; 2(3 Suppl):35-6. PubMed ID: 745581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic evaluation of growth hormone (GH) and prolactin (hPRL) secretion in active acromegaly with high and low GH output.
    Tolis G; Kovacs L; Friesen H; Martin JB
    Acta Endocrinol (Copenh); 1975 Feb; 78(2):251-7. PubMed ID: 803748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The growth hormone responses to L-dopa and TRH in acromegaly.
    Jialal I; Naidoo C; Nathoo BC; Rajput MC; Joubert SM
    J Endocrinol Invest; 1984 Jun; 7(3):235-7. PubMed ID: 6432894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.